Pacer Advisors
CGEM icon

Pacer Advisors’s Cullinan Oncology CGEM Stock Holding History

Pacer Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
+1,104
New +$16.4K ﹤0.01% 2254
2024
Q3 		– Sell
-595
Closed -$10.4K – 2587
2024
Q2 		$10.4K Buy
595
+145
+32% +$3.09K ﹤0.01% 3544
2024
Q1 		$7.67K Buy
+450
New +$6.95K ﹤0.01% 3568

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Pacer Advisors's CGEM Position: Q2 2026 in Review

Pacer Advisors opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 1,104 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #2254 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in CGEM as recently as Q2 2024.

Pacer Advisors first reported a position in CGEM in Q1 2024 and has held it in 3 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Pacer Advisors held 1,104 shares of Cullinan Oncology worth $20K as of Q2 2026.
  • Cullinan Oncology was a new Pacer Advisors position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2254 holding.
  • Pacer Advisors first reported a position in Cullinan Oncology in Q1 2024 and has held it in 3 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.